AMH and ovarian reserve are often described as an ovarian clock. The test can help estimate response to stimulation, but it cannot count every remaining egg, measure egg quality or predict a personal menopause date. Age, ultrasound findings and clinical history give the number its meaning.
When assessing ovarian function, we look at a constellation of factors. While ovarian volume (via ultrasound) and basic blood markers like FSH (Follicle-Stimulating Hormone) and Estradiol (E2) provide a snapshot of current hormonal responsiveness, one metric stands out for its reliability: AMH (Anti-Müllerian Hormone).
What AMH reflects
Anti-Müllerian hormone is produced by granulosa cells in small growing follicles. It is an indirect marker of the follicle pool, not an exact count of all remaining eggs.
A useful marker with limits
AMH is useful for estimating ovarian response to stimulation. It cannot convert reliably into a single personal “ovarian age.”
- Age: Helps interpret the result; there is no exact AMH-to-age conversion.
- Assay: Units and laboratory methods affect comparisons.
- Ultrasound: Antral follicle count provides complementary information.
- Clinical context: Hormonal contraception and other factors may affect interpretation.
- Limits: A low value cannot provide a precise menopause deadline.
Higher AMH may be seen in PCOS, but no universal AMH cutoff diagnoses the condition across ages and assays. Symptoms and appropriate diagnostic criteria matter.
The Important Distinction: Quantity vs. Quality
The most critical takeaway for patients is this: AMH reflects the quantity of your ovarian reserve, not the quality of the eggs.
A higher AMH does not automatically guarantee higher quality or a higher chance of a genetically normal embryo, especially as maternal age advances. Even with a decent reserve, age remains the dominant factor determining the chromosomal health and viability of the eggs. Therefore, AMH should never be viewed as a standalone measure of pregnancy potential; it must be interpreted alongside your chronological age, chromosomal health, and overall reproductive environment.
Very low AMH may indicate a low expected response to stimulation. It does not reliably state that menopause will arrive within a particular number of years or that natural conception is impossible.
Conclusion: A Compass, Not a Verdict
In modern fertility care, we rely on three pillars to assess your ovarian status:
- Ultrasound: To assess structural health and antral follicle count (AFC).
- Hormonal Markers (FSH/E2): To measure current responsiveness.
- AMH: To gauge the remaining reserve.
Read the clock carefully
A single measurement does not show how fast reserve is changing. Discuss age, ultrasound, assay variation and reproductive goals rather than making a life decision from one result.
Disclaimer: This report is for informational purposes. Ovarian reserve testing is complex; always review your specific AMH results and their clinical implications with a board-certified reproductive endocrinologist.
Reserve is not reproductive destiny
Use AMH for the clinical question it can answer, with age and other findings. Neither a high nor a low value guarantees an outcome. ASRM ovarian-reserve guidance (2020).
Related reading
"The AMH Trap": Why One Number Does Not Define Your Fertility Future